US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Inhibikase Therapeutics, Inc.

1.83

+0.13007.65%

Post-market: 1.980.1500+8.20%19:59 EDT

Volume:1.62M

Turnover:2.92M

Market Cap:241.56M

PE:-3.73

High:1.85

Open:1.73

Low:1.72

Close:1.70

52wk High:2.37

52wk Low:1.33

Shares:132.00M

Float Shares:61.84M

Volume Ratio:1.62

T/O Rate:2.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4909

EPS(LYR):-0.3086

ROE:-36.05%

ROA:-20.53%

PB:1.40

PE(LYR):-5.93

Loading ...

Overview Company News Filings

Buy Rating on IKT-001: De-Risked Late-Stage PAH Program with Adaptive Phase 3 Design and Solid Financial Runway

Inhibikase Therapeutics: Phase 3 IKT-001 PAH Program and De-Risked Imatinib-Based Efficacy Drive Buy Rating and $8 Target

Inhibikase Begins Pivotal Phase 3 Trial in PAH

Inhibikase enrolls first patient in Phase 3 IMPROVE-PAH trial for IKT-001

Inhibikase Therapeutics Announces Enrollment of First Patient in Improve-Pah Global Phase 3 Study of Ikt-001 in the Treatment of Pulmonary Arterial Hypertension

THOMSON REUTERS

Inhibikase grants 685,718 inducement stock options to five new hires at $1.68/share

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inhibikase Therapeutics (IKT) Receives a Buy from H.C. Wainwright

Inhibikase Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Inhibikase Therapeutics FY2025 net loss widens 75.39% to $48 million; R&D expenses climb 73.13% to $30 million

Inhibikase Therapeutics Q1 EPS $(0.10) Beats $(0.13) Estimate

Press Release: Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity

Calendar of U.S. Earnings Expected in the Week Ahead

Inhibikase Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Inhibikase Therapeutics Initiated at Buy by Ladenburg Thalmann

Ladenburg Thalmann Initiates Inhibikase Therapeutics at Buy

MT Newswires Live

Buy Rating on Inhibikase Therapeutics Driven by Rival PAH Setback and Pivotal Phase 3 IMPROVE-PAH Trial for IKT-001

Analysts’ Top Healthcare Picks: Inhibikase Therapeutics (IKT), Tvardi Therapeutics (TVRD)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IKT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IKT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IKT\",,,,,undefined,":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":1.83,"timestamp":1776456000000,"preClose":1.7,"halted":0,"volume":1620279,"hourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.83,"latestTime":"19:59 EDT","volume":20918,"amount":40302.8,"timestamp":1776470357832,"change":0.15,"changeRate":0.081967,"amplitude":0.131148},"delay":0,"changeRate":0.07647058823529419,"floatShares":61839000,"shares":132000000,"eps":-0.490886,"marketStatus":"Market Closed","change":0.13,"latestTime":"04-17 16:00:00 EDT","open":1.73,"high":1.85,"low":1.72,"amount":2915557.0912593002,"amplitude":0.076471,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.490886,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"listingDate":1608699600000,"exchange":"NASDAQ","adjPreClose":1.7,"preHourTrading":{"tag":"盘前","latestPrice":1.74,"preClose":1.7,"latestTime":"08:29 EDT","volume":49,"amount":84.5800025,"timestamp":1776428987888,"change":0.04,"changeRate":0.023529,"amplitude":0.023529},"postHourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.83,"latestTime":"19:59 EDT","volume":20918,"amount":40302.8,"timestamp":1776470357832,"change":0.15,"changeRate":0.081967,"amplitude":0.131148},"volumeRatio":1.6216333598638828},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IKT\",,,,,undefined,":{"symbol":"IKT","floatShares":61839000,"roa":"-20.53%","roe":"-36.05%","lyrEps":-0.308596,"volumeRatio":1.6216333598638828,"shares":132000000,"dividePrice":0,"high":1.85,"amplitude":0.076471,"preClose":1.7,"low":1.72,"week52Low":1.33,"pbRate":"1.40","psRate":"241560000.00","week52High":2.365,"institutionHeld":0,"latestPrice":1.83,"eps":-0.490886,"divideRate":0,"volume":1620279,"delay":0,"ttmEps":-0.490886,"open":1.73,"prevYearClose":2.05,"prevWeekClose":1.7,"prevMonthClose":1.68,"prevQuarterClose":1.68,"fiveDayClose":1.7,"twentyDayClose":1.83,"sixtyDayClose":1.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IKT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-26","symbol":"IKT","fiscalQuarterEnding":"2025/12","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2025-11-14","symbol":"IKT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-14","symbol":"IKT","fiscalQuarterEnding":"2025/06","expectedEps":-0.09,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-05-14","symbol":"IKT","fiscalQuarterEnding":"2025/03","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.15},{"date":"2025-03-27","symbol":"IKT","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743105600000,"name":null,"time":"Post Market","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IKT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IKT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1772683200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IKT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IKT","date":"2026-04-16","current":-3.727953,"percent":0.201954,"low":-21.034161,"twenty":-6.373209,"median":-2.200917,"eighty":-0.714734,"high":-0.227656,"avg":-3.670086,"sd":3.946746,"marketCap":305055906},"quantilePoints":[{"date":"2021-04-23","current":-21.034161,"twenty":-44.283847,"median":-34.062803,"eighty":-27.33745,"marketCap":59903060},{"date":"2021-04-30","current":-18.474357,"twenty":-44.283847,"median":-33.698384,"eighty":-25.249509,"marketCap":52613010},{"date":"2021-05-07","current":-19.074862,"twenty":-44.283847,"median":-33.16426,"eighty":-21.034161,"marketCap":54323184},{"date":"2021-05-14","current":-16.213632,"twenty":-44.283847,"median":-32.533022,"eighty":-19.975394,"marketCap":46174706},{"date":"2021-05-21","current":-9.55554,"twenty":-39.647493,"median":-32.508744,"eighty":-19.622472,"marketCap":47180691},{"date":"2021-05-28","current":-10.900243,"twenty":-38.602616,"median":-32.193125,"eighty":-19.128381,"marketCap":53820192},{"date":"2021-06-04","current":-10.716875,"twenty":-38.136471,"median":-31.853228,"eighty":-18.838369,"marketCap":52914805},{"date":"2021-06-11","current":-12.223376,"twenty":-37.942244,"median":-31.707557,"eighty":-18.473862,"marketCap":60353189},{"date":"2021-06-18","current":-14.761798,"twenty":-37.922821,"median":-31.027763,"eighty":-18.234155,"marketCap":72886700},{"date":"2021-06-25","current":-14.863603,"twenty":-37.689749,"median":-30.639309,"eighty":-17.089663,"marketCap":73389367},{"date":"2021-07-02","current":-14.25277,"twenty":-37.243027,"median":-29.765287,"eighty":-14.843242,"marketCap":70373366},{"date":"2021-07-09","current":-13.845548,"twenty":-37.000243,"median":-28.308585,"eighty":-14.741437,"marketCap":68362698},{"date":"2021-07-16","current":-12.318465,"twenty":-36.873995,"median":-27.920131,"eighty":-14.395298,"marketCap":60822694},{"date":"2021-07-23","current":-12.420271,"twenty":-36.650634,"median":-27.33745,"eighty":-14.089881,"marketCap":61325361},{"date":"2021-07-30","current":-11.554924,"twenty":-36.427273,"median":-26.123531,"eighty":-13.367062,"marketCap":57052693},{"date":"2021-08-06","current":-10.994994,"twenty":-36.310737,"median":-21.98705,"eighty":-12.594554,"marketCap":54288025},{"date":"2021-08-13","current":-9.722425,"twenty":-36.271892,"median":-21.122391,"eighty":-12.280429,"marketCap":48004688},{"date":"2021-08-20","current":-6.641938,"twenty":-36.126222,"median":-20.787115,"eighty":-11.982508,"marketCap":47502022},{"date":"2021-08-27","current":-7.801641,"twenty":-35.708634,"median":-19.904809,"eighty":-11.669916,"marketCap":55796025},{"date":"2021-09-03","current":-8.469349,"twenty":-35.46585,"median":-19.657764,"eighty":-11.488131,"marketCap":60571361},{"date":"2021-09-10","current":-8.047639,"twenty":-35.446427,"median":-19.357452,"eighty":-11.178507,"marketCap":57555360},{"date":"2021-09-17","current":-7.169075,"twenty":-35.388159,"median":-19.146027,"eighty":-10.964452,"marketCap":51272023},{"date":"2021-09-24","current":-7.133933,"twenty":-35.261911,"median":-18.972776,"eighty":-10.790222,"marketCap":51020690},{"date":"2021-10-01","current":-6.81765,"twenty":-35.203643,"median":-18.63429,"eighty":-10.097489,"marketCap":48758689},{"date":"2021-10-08","current":-6.466225,"twenty":-35.106529,"median":-18.474357,"eighty":-9.686832,"marketCap":46245354},{"date":"2021-10-15","current":-6.782508,"twenty":-34.902591,"median":-18.324861,"eighty":-9.266226,"marketCap":48507355},{"date":"2021-10-22","current":-6.53651,"twenty":-34.795766,"median":-18.121119,"eighty":-8.483406,"marketCap":46748021},{"date":"2021-10-29","current":-6.993363,"twenty":-34.766632,"median":-17.530327,"eighty":-8.183189,"marketCap":50015356},{"date":"2021-11-05","current":-7.590786,"twenty":-34.74721,"median":-15.525339,"eighty":-7.801641,"marketCap":54288025},{"date":"2021-11-12","current":-7.063648,"twenty":-34.60154,"median":-14.812701,"eighty":-7.604843,"marketCap":50518023},{"date":"2021-11-19","current":-4.36386,"twenty":-34.349044,"median":-14.761798,"eighty":-7.464273,"marketCap":47794876},{"date":"2021-11-26","current":-4.731343,"twenty":-34.213182,"median":-14.710895,"eighty":-7.344788,"marketCap":51819707},{"date":"2021-12-03","current":-3.789668,"twenty":-34.106649,"median":-14.380027,"eighty":-7.204218,"marketCap":41506076},{"date":"2021-12-10","current":-3.835604,"twenty":-33.95088,"median":-14.25277,"eighty":-7.140961,"marketCap":42009180},{"date":"2021-12-17","current":-3.743733,"twenty":-33.776075,"median":-13.845548,"eighty":-7.035534,"marketCap":41002972},{"date":"2021-12-23","current":-3.605927,"twenty":-33.698384,"median":-13.565583,"eighty":-6.95822,"marketCap":39493660},{"date":"2021-12-31","current":-3.37625,"twenty":-33.504157,"median":-13.13291,"eighty":-6.81765,"marketCap":36978141},{"date":"2022-01-07","current":-3.330315,"twenty":-33.212817,"median":-12.587222,"eighty":-6.747365,"marketCap":36475037},{"date":"2022-01-14","current":-3.835604,"twenty":-33.115703,"median":-12.420271,"eighty":-6.67708,"marketCap":42009180},{"date":"2022-01-21","current":-3.034368,"twenty":-32.688404,"median":-12.223376,"eighty":-6.641938,"marketCap":33233707},{"date":"2022-01-28","current":-2.873455,"twenty":-32.542733,"median":-12.140306,"eighty":-6.53651,"marketCap":31471313},{"date":"2022-02-04","current":-2.988393,"twenty":-32.533022,"median":-11.857835,"eighty":-6.34674,"marketCap":32730166},{"date":"2022-02-11","current":-2.873685,"twenty":-32.533022,"median":-11.660488,"eighty":-5.898377,"marketCap":31473831},{"date":"2022-02-18","current":-2.52864,"twenty":-32.494176,"median":-11.554924,"eighty":-4.667034,"marketCap":27694756},{"date":"2022-02-25","current":-2.482665,"twenty":-32.397063,"median":-11.453119,"eighty":-4.405202,"marketCap":27191215},{"date":"2022-03-04","current":-2.505653,"twenty":-32.251393,"median":-11.181857,"eighty":-4.203087,"marketCap":27442985},{"date":"2022-03-11","current":-3.172294,"twenty":-32.105723,"median":-10.994994,"eighty":-3.922881,"marketCap":34744330},{"date":"2022-03-18","current":-3.31022,"twenty":-31.930919,"median":-10.942542,"eighty":-3.835604,"marketCap":36254953},{"date":"2022-03-25","current":-3.195282,"twenty":-31.824094,"median":-10.900243,"eighty":-3.780481,"marketCap":34996100},{"date":"2022-04-01","current":-2.456837,"twenty":-31.746403,"median":-10.503575,"eighty":-3.734546,"marketCap":36326953},{"date":"2022-04-08","current":-2.345939,"twenty":-31.707557,"median":-9.974245,"eighty":-3.67483,"marketCap":34687195},{"date":"2022-04-14","current":-2.166794,"twenty":-31.493907,"median":-9.722425,"eighty":-3.578365,"marketCap":32038354},{"date":"2022-04-22","current":-2.056919,"twenty":-31.115165,"median":-9.677786,"eighty":-3.445153,"marketCap":30413732},{"date":"2022-04-29","current":-1.842628,"twenty":-30.988917,"median":-9.351798,"eighty":-3.386618,"marketCap":27245215},{"date":"2022-05-06","current":-1.629361,"twenty":-30.814113,"median":-8.539634,"eighty":-3.318258,"marketCap":24091833},{"date":"2022-05-13","current":-1.143112,"twenty":-30.639309,"median":-8.469349,"eighty":-3.287232,"marketCap":16902124},{"date":"2022-05-20","current":-0.985967,"twenty":-30.445082,"median":-8.287361,"eighty":-3.218269,"marketCap":16553990},{"date":"2022-05-27","current":-1.406378,"twenty":-29.998359,"median":-8.047639,"eighty":-3.181489,"marketCap":23612519},{"date":"2022-06-03","current":-1.420051,"twenty":-29.590483,"median":-7.801641,"eighty":-3.153354,"marketCap":23842085},{"date":"2022-06-10","current":-1.427414,"twenty":-28.77473,"median":-7.696213,"eighty":-3.080344,"marketCap":23965698},{"date":"2022-06-17","current":-1.30721,"twenty":-28.26974,"median":-7.590786,"eighty":-3.015978,"marketCap":21947534},{"date":"2022-06-24","current":-1.223369,"twenty":-28.114358,"median":-7.590786,"eighty":-2.965405,"marketCap":20539864},{"date":"2022-07-01","current":-1.141931,"twenty":-28.114358,"median":-7.415074,"eighty":-2.873455,"marketCap":19172558},{"date":"2022-07-08","current":-1.300148,"twenty":-27.803595,"median":-7.344788,"eighty":-2.834376,"marketCap":21828967},{"date":"2022-07-15","current":-1.265289,"twenty":-27.531677,"median":-7.309646,"eighty":-2.58381,"marketCap":21243699},{"date":"2022-07-22","current":-1.367162,"twenty":-27.366584,"median":-7.186647,"eighty":-2.501055,"marketCap":22954093},{"date":"2022-07-29","current":-1.277008,"twenty":-27.143223,"median":-7.169075,"eighty":-2.43669,"marketCap":21440445},{"date":"2022-08-05","current":-1.217058,"twenty":-26.97813,"median":-7.09879,"eighty":-2.384419,"marketCap":20433911},{"date":"2022-08-12","current":-1.242066,"twenty":-25.628252,"median":-7.028505,"eighty":-2.286224,"marketCap":23342590},{"date":"2022-08-19","current":-1.013332,"twenty":-25.25922,"median":-6.975791,"eighty":-2.159969,"marketCap":19043900},{"date":"2022-08-26","current":-1.293612,"twenty":-22.639542,"median":-6.852793,"eighty":-2.051596,"marketCap":24311309},{"date":"2022-09-02","current":-1.246764,"twenty":-21.394141,"median":-6.81765,"eighty":-1.900637,"marketCap":23430884},{"date":"2022-09-09","current":-1.234683,"twenty":-21.224739,"median":-6.782508,"eighty":-1.842628,"marketCap":23203841},{"date":"2022-09-16","current":-1.369186,"twenty":-21.104745,"median":-6.747365,"eighty":-1.646763,"marketCap":25731592},{"date":"2022-09-23","current":-1.140988,"twenty":-20.970635,"median":-6.67708,"eighty":-1.511556,"marketCap":21442993},{"date":"2022-09-30","current":-1.221528,"twenty":-20.843583,"median":-6.67708,"eighty":-1.424469,"marketCap":22956616},{"date":"2022-10-07","current":-1.181258,"twenty":-20.617712,"median":-6.589224,"eighty":-1.382337,"marketCap":22199804},{"date":"2022-10-14","current":-1.110248,"twenty":-20.187147,"median":-6.53651,"eighty":-1.368376,"marketCap":20865293},{"date":"2022-10-21","current":-1.087429,"twenty":-19.890693,"median":-6.431083,"eighty":-1.350664,"marketCap":20436434},{"date":"2022-10-28","current":-1.042595,"twenty":-19.791875,"median":-6.290512,"eighty":-1.332174,"marketCap":19593850},{"date":"2022-11-04","current":-1.033601,"twenty":-19.700115,"median":-6.149942,"eighty":-1.309645,"marketCap":19424829},{"date":"2022-11-11","current":-0.671169,"twenty":-19.636589,"median":-4.731343,"eighty":-1.299367,"marketCap":12613525},{"date":"2022-11-18","current":-0.96515,"twenty":-19.46346,"median":-4.639473,"eighty":-1.293041,"marketCap":18160954},{"date":"2022-11-25","current":-0.898116,"twenty":-19.27994,"median":-4.490183,"eighty":-1.285241,"marketCap":16899601},{"date":"2022-12-02","current":-0.76968,"twenty":-19.163673,"median":-4.340893,"eighty":-1.27716,"marketCap":14482849},{"date":"2022-12-09","current":-0.656929,"twenty":-19.149556,"median":-4.191603,"eighty":-1.274845,"marketCap":12361254},{"date":"2022-12-16","current":-0.729996,"twenty":-19.106973,"median":-4.06528,"eighty":-1.265289,"marketCap":13736129},{"date":"2022-12-23","current":-0.663566,"twenty":-19.034028,"median":-3.870055,"eighty":-1.259005,"marketCap":12486128},{"date":"2022-12-30","current":-0.670336,"twenty":-18.950805,"median":-3.847087,"eighty":-1.245737,"marketCap":12613525},{"date":"2023-01-06","current":-0.742598,"twenty":-18.862919,"median":-3.835604,"eighty":-1.232083,"marketCap":13973263},{"date":"2023-01-13","current":-0.804403,"twenty":-18.740167,"median":-3.789668,"eighty":-1.221528,"marketCap":15136230},{"date":"2023-01-20","current":-0.911791,"twenty":-18.570764,"median":-3.766701,"eighty":-1.213608,"marketCap":17156917},{"date":"2023-01-27","current":-0.980103,"twenty":-18.500179,"median":-3.732249,"eighty":-1.20689,"marketCap":18442318},{"date":"2023-02-03","current":-1.14529,"twenty":-18.47811,"median":-3.67483,"eighty":-1.199756,"marketCap":21550606},{"date":"2023-02-10","current":-1.084965,"twenty":-18.472379,"median":-3.67483,"eighty":-1.186663,"marketCap":20415478},{"date":"2023-02-17","current":-1.132033,"twenty":-18.360826,"median":-3.559991,"eighty":-1.181258,"marketCap":21301158},{"date":"2023-02-24","current":-1.06426,"twenty":-18.323221,"median":-3.468121,"eighty":-1.174956,"marketCap":20025891},{"date":"2023-03-03","current":-1.087348,"twenty":-18.284112,"median":-3.433669,"eighty":-1.154787,"marketCap":20460323},{"date":"2023-03-10","current":-0.988593,"twenty":-18.177637,"median":-3.402171,"eighty":-1.144419,"marketCap":18602077},{"date":"2023-03-17","current":-0.968186,"twenty":-18.111392,"median":-3.356195,"eighty":-1.141554,"marketCap":18218096},{"date":"2023-03-24","current":-1.072453,"twenty":-17.893153,"median":-3.31022,"eighty":-1.133379,"marketCap":20180044},{"date":"2023-03-31","current":-0.979507,"twenty":-17.485996,"median":-3.287232,"eighty":-1.127007,"marketCap":18431107},{"date":"2023-04-06","current":-0.962818,"twenty":-16.870655,"median":-3.275739,"eighty":-1.115257,"marketCap":17382866},{"date":"2023-04-14","current":-0.90041,"twenty":-15.938315,"median":-3.218269,"eighty":-1.110039,"marketCap":16256147},{"date":"2023-04-21","current":-0.979061,"twenty":-15.301367,"median":-3.195282,"eighty":-1.10135,"marketCap":17676115},{"date":"2023-04-28","current":-0.847449,"twenty":-14.924687,"median":-3.172294,"eighty":-1.087348,"marketCap":15299981},{"date":"2023-05-05","current":-0.908841,"twenty":-14.822881,"median":-3.159424,"eighty":-1.080973,"marketCap":16408361},{"date":"2023-05-12","current":-1.06513,"twenty":-14.761798,"median":-3.103331,"eighty":-1.075133,"marketCap":19230022},{"date":"2023-05-19","current":-1.087321,"twenty":-14.761798,"median":-3.06885,"eighty":-1.075133,"marketCap":19453627},{"date":"2023-05-26","current":-1.054688,"twenty":-14.741437,"median":-3.034368,"eighty":-1.075133,"marketCap":18869770},{"date":"2023-06-02","current":-1.224972,"twenty":-14.710895,"median":-2.988393,"eighty":-1.075106,"marketCap":21916387},{"date":"2023-06-09","current":-1.203101,"twenty":-14.690534,"median":-2.930924,"eighty":-1.075508,"marketCap":21525078},{"date":"2023-06-16","current":-1.09357,"twenty":-14.578547,"median":-2.873455,"eighty":-1.077034,"marketCap":19565429},{"date":"2023-06-23","current":-1.138702,"twenty":-14.456381,"median":-2.873455,"eighty":-1.075079,"marketCap":20372892},{"date":"2023-06-30","current":-1.058854,"twenty":-14.334215,"median":-2.850467,"eighty":-1.074596,"marketCap":18944301},{"date":"2023-07-07","current":-0.807159,"twenty":-14.273131,"median":-2.758517,"eighty":-1.071179,"marketCap":14441151},{"date":"2023-07-14","current":-0.856341,"twenty":-14.25277,"median":-2.563122,"eighty":-1.065502,"marketCap":15321078},{"date":"2023-07-21","current":-0.815838,"twenty":-14.25277,"median":-2.505653,"eighty":-1.060533,"marketCap":14596432},{"date":"2023-07-28","current":-0.720368,"twenty":-14.008437,"median":-2.471171,"eighty":-1.056231,"marketCap":12888339},{"date":"2023-08-04","current":-0.73194,"twenty":-13.845548,"median":-2.43669,"eighty":-1.052021,"marketCap":13095381},{"date":"2023-08-11","current":-0.723261,"twenty":-13.784465,"median":-2.401147,"eighty":-1.049135,"marketCap":12940100},{"date":"2023-08-18","current":-0.649241,"twenty":-13.529951,"median":-2.367727,"eighty":-1.042635,"marketCap":12354633},{"date":"2023-08-25","current":-0.59584,"twenty":-13.356881,"median":-2.324612,"eighty":-1.037749,"marketCap":11338451},{"date":"2023-09-01","current":-0.564924,"twenty":-13.214354,"median":-2.200917,"eighty":-1.03213,"marketCap":10750135},{"date":"2023-09-08","current":-0.576166,"twenty":-13.031104,"median":-2.166794,"eighty":-1.02724,"marketCap":10964068},{"date":"2023-09-15","current":-0.472175,"twenty":-12.77659,"median":-2.081488,"eighty":-1.013056,"marketCap":8985187},{"date":"2023-09-22","current":-0.351321,"twenty":-12.594554,"median":-2.030303,"eighty":-1.006224,"marketCap":6685407},{"date":"2023-09-29","current":-0.404721,"twenty":-12.498445,"median":-1.927935,"eighty":-0.982895,"marketCap":7701589},{"date":"2023-10-06","current":-0.252951,"twenty":-12.420271,"median":-1.859689,"eighty":-0.979239,"marketCap":4813493},{"date":"2023-10-13","current":-0.259078,"twenty":-12.379549,"median":-1.842628,"eighty":-0.960141,"marketCap":4930086},{"date":"2023-10-20","current":-0.261383,"twenty":-12.280429,"median":-1.658365,"eighty":-0.935074,"marketCap":4973943},{"date":"2023-10-27","current":-0.236087,"twenty":-12.242394,"median":-1.629361,"eighty":-0.931552,"marketCap":4492593},{"date":"2023-11-03","current":-0.303541,"twenty":-12.218003,"median":-1.525079,"eighty":-0.924262,"marketCap":5776192},{"date":"2023-11-10","current":-0.281057,"twenty":-12.21666,"median":-1.489996,"eighty":-0.908627,"marketCap":5348326},{"date":"2023-11-17","current":-0.265599,"twenty":-12.094494,"median":-1.423732,"eighty":-0.89787,"marketCap":5080909},{"date":"2023-11-24","current":-0.280796,"twenty":-11.941785,"median":-1.401194,"eighty":-0.889896,"marketCap":5371623},{"date":"2023-12-01","current":-0.302582,"twenty":-11.858837,"median":-1.382337,"eighty":-0.877765,"marketCap":5788387},{"date":"2023-12-08","current":-0.374394,"twenty":-11.833386,"median":-1.372606,"eighty":-0.865483,"marketCap":7162164},{"date":"2023-12-15","current":-0.422808,"twenty":-11.751414,"median":-1.358146,"eighty":-0.857354,"marketCap":8088306},{"date":"2023-12-22","current":-0.40667,"twenty":-11.688774,"median":-1.354024,"eighty":-0.853448,"marketCap":7779592},{"date":"2023-12-29","current":-0.39376,"twenty":-11.651059,"median":-1.350259,"eighty":-0.851677,"marketCap":7532621},{"date":"2024-01-05","current":-0.43249,"twenty":-11.61184,"median":-1.341619,"eighty":-0.846797,"marketCap":8273535},{"date":"2024-01-12","current":-0.4454,"twenty":-11.595646,"median":-1.331653,"eighty":-0.830808,"marketCap":8520506},{"date":"2024-01-19","current":-0.561592,"twenty":-11.554924,"median":-1.318029,"eighty":-0.815838,"marketCap":10743247},{"date":"2024-01-26","current":-0.793974,"twenty":-11.511472,"median":-1.307438,"eighty":-0.804403,"marketCap":15188728},{"date":"2024-02-02","current":-0.876363,"twenty":-11.453119,"median":-1.299848,"eighty":-0.807159,"marketCap":16764818},{"date":"2024-02-09","current":-0.889298,"twenty":-11.198605,"median":-1.296664,"eighty":-0.811375,"marketCap":17012270},{"date":"2024-02-16","current":-0.766413,"twenty":-11.198605,"median":-1.292898,"eighty":-0.807159,"marketCap":14661483},{"date":"2024-02-23","current":-0.704971,"twenty":-11.171808,"median":-1.287142,"eighty":-0.801128,"marketCap":13486090},{"date":"2024-03-01","current":-0.698503,"twenty":-11.110462,"median":-1.27746,"eighty":-0.787359,"marketCap":13362364},{"date":"2024-03-08","current":-0.782582,"twenty":-11.015355,"median":-1.27716,"eighty":-0.775336,"marketCap":14970797},{"date":"2024-03-15","current":-0.688802,"twenty":-10.994994,"median":-1.277009,"eighty":-0.769673,"marketCap":13176776},{"date":"2024-03-22","current":-0.714672,"twenty":-10.954272,"median":-1.271628,"eighty":-0.760981,"marketCap":13671678},{"date":"2024-03-28","current":-0.747729,"twenty":-10.942232,"median":-1.267168,"eighty":-0.74613,"marketCap":14228444},{"date":"2024-04-05","current":-0.748812,"twenty":-10.916543,"median":-1.262134,"eighty":-0.740589,"marketCap":14249056},{"date":"2024-04-12","current":-0.765831,"twenty":-10.900243,"median":-1.2595,"eighty":-0.739435,"marketCap":14572899},{"date":"2024-04-19","current":-0.714775,"twenty":-10.790222,"median":-1.249968,"eighty":-0.736464,"marketCap":13601372},{"date":"2024-04-26","current":-0.646701,"twenty":-10.669955,"median":-1.243773,"eighty":-0.73194,"marketCap":12306003},{"date":"2024-05-03","current":-0.456095,"twenty":-10.476555,"median":-1.234346,"eighty":-0.731794,"marketCap":8678970},{"date":"2024-05-10","current":-0.462902,"twenty":-10.316803,"median":-1.227143,"eighty":-0.728471,"marketCap":8808507},{"date":"2024-05-17","current":-0.593688,"twenty":-10.097489,"median":-1.223369,"eighty":-0.724986,"marketCap":11399245},{"date":"2024-05-24","current":-0.685401,"twenty":-9.881942,"median":-1.218535,"eighty":-0.723828,"marketCap":13160208},{"date":"2024-05-31","current":-0.67791,"twenty":-9.781214,"median":-1.215082,"eighty":-0.721304,"marketCap":13016381},{"date":"2024-06-07","current":-0.62173,"twenty":-9.713616,"median":-1.20985,"eighty":-0.718891,"marketCap":11937675},{"date":"2024-06-14","current":-0.575014,"twenty":-9.695879,"median":-1.208105,"eighty":-0.715401,"marketCap":11040701},{"date":"2024-06-21","current":-0.537432,"twenty":-9.677786,"median":-1.203101,"eighty":-0.711689,"marketCap":10319087},{"date":"2024-06-28","current":-0.514882,"twenty":-9.677786,"median":-1.202032,"eighty":-0.703794,"marketCap":9886118},{"date":"2024-07-05","current":-0.432388,"twenty":-9.653337,"median":-1.201796,"eighty":-0.699245,"marketCap":8302174},{"date":"2024-07-12","current":-0.511124,"twenty":-9.514792,"median":-1.195069,"eighty":-0.694483,"marketCap":9813957},{"date":"2024-07-15","current":-0.546827,"twenty":-9.474043,"median":-1.194248,"eighty":-0.694339,"marketCap":10499490},{"date":"2024-08-02","current":-0.514882,"twenty":-9.433295,"median":-1.193294,"eighty":-0.694166,"marketCap":9886118},{"date":"2024-08-09","current":-0.484816,"twenty":-9.266226,"median":-1.189983,"eighty":-0.690006,"marketCap":9308827},{"date":"2024-08-16","current":-0.482846,"twenty":-8.807452,"median":-1.186146,"eighty":-0.683019,"marketCap":8875858},{"date":"2024-08-23","current":-0.556281,"twenty":-8.539634,"median":-1.181258,"eighty":-0.67791,"marketCap":10225775},{"date":"2024-08-30","current":-0.562981,"twenty":-8.518548,"median":-1.18081,"eighty":-0.674691,"marketCap":10348933},{"date":"2024-09-06","current":-0.552221,"twenty":-8.490434,"median":-1.177036,"eighty":-0.670336,"marketCap":10151135},{"date":"2024-09-13","current":-0.487254,"twenty":-8.413121,"median":-1.169079,"eighty":-0.658277,"marketCap":8956884},{"date":"2024-09-20","current":-0.471134,"twenty":-8.314722,"median":-1.157566,"eighty":-0.652769,"marketCap":8660560},{"date":"2024-09-27","current":-0.466951,"twenty":-8.288616,"median":-1.152978,"eighty":-0.645274,"marketCap":8583680},{"date":"2024-10-04","current":-0.515677,"twenty":-8.215822,"median":-1.145645,"eighty":-0.643523,"marketCap":9479368},{"date":"2024-10-11","current":-0.527858,"twenty":-8.08981,"median":-1.143909,"eighty":-0.63691,"marketCap":9703291},{"date":"2024-10-18","current":-0.954205,"twenty":-7.977354,"median":-1.141931,"eighty":-0.63691,"marketCap":17540564},{"date":"2024-10-25","current":-1.023233,"twenty":-7.843812,"median":-1.140988,"eighty":-0.63754,"marketCap":18809456},{"date":"2024-10-31","current":-10.125098,"twenty":-8.103867,"median":-1.141931,"eighty":-0.637913,"marketCap":186123418},{"date":"2024-11-08","current":-10.161651,"twenty":-8.441235,"median":-1.143511,"eighty":-0.640228,"marketCap":186795344},{"date":"2024-11-15","current":-8.626437,"twenty":-8.609076,"median":-1.145645,"eighty":-0.643523,"marketCap":158574465},{"date":"2024-11-22","current":-6.902906,"twenty":-8.539634,"median":-1.151436,"eighty":-0.643542,"marketCap":135057065},{"date":"2024-11-29","current":-10.028102,"twenty":-8.539634,"median":-1.154747,"eighty":-0.643619,"marketCap":196202304},{"date":"2024-12-06","current":-9.375588,"twenty":-9.351798,"median":-1.166315,"eighty":-0.644323,"marketCap":183435716},{"date":"2024-12-13","current":-11.127072,"twenty":-9.540255,"median":-1.171959,"eighty":-0.644323,"marketCap":217703926},{"date":"2024-12-20","current":-10.852329,"twenty":-9.649913,"median":-1.178842,"eighty":-0.645611,"marketCap":212328521},{"date":"2024-12-27","current":-10.508901,"twenty":-9.689253,"median":-1.181258,"eighty":-0.646483,"marketCap":205609264},{"date":"2025-01-03","current":-11.298786,"twenty":-9.825314,"median":-1.181258,"eighty":-0.647449,"marketCap":221063555},{"date":"2025-01-10","current":-10.646272,"twenty":-10.023037,"median":-1.185285,"eighty":-0.648465,"marketCap":208296967},{"date":"2025-01-17","current":-9.478617,"twenty":-10.023037,"median":-1.188991,"eighty":-0.649543,"marketCap":185451493},{"date":"2025-01-24","current":-9.719016,"twenty":-10.007201,"median":-1.191902,"eighty":-0.651383,"marketCap":190154973},{"date":"2025-01-31","current":-6.59382,"twenty":-9.945931,"median":-1.19589,"eighty":-0.656956,"marketCap":129009734},{"date":"2025-02-07","current":-8.345304,"twenty":-9.830222,"median":-1.201839,"eighty":-0.657186,"marketCap":163277945},{"date":"2025-02-14","current":-7.658447,"twenty":-9.80081,"median":-1.203101,"eighty":-0.657672,"marketCap":149839431},{"date":"2025-02-21","current":-11.557305,"twenty":-9.832676,"median":-1.208105,"eighty":-0.657672,"marketCap":226121551},{"date":"2025-02-28","current":-8.295734,"twenty":-9.832676,"median":-1.212199,"eighty":-0.659184,"marketCap":162308107},{"date":"2025-03-07","current":-7.480342,"twenty":-9.820406,"median":-1.215085,"eighty":-0.662931,"marketCap":146354746},{"date":"2025-03-14","current":-7.799408,"twenty":-9.722425,"median":-1.220769,"eighty":-0.663566,"marketCap":152597365},{"date":"2025-03-21","current":-8.579349,"twenty":-9.719016,"median":-1.224571,"eighty":-0.670336,"marketCap":167857102},{"date":"2025-03-28","current":-8.40209,"twenty":-9.700402,"median":-1.230698,"eighty":-0.670336,"marketCap":164388980},{"date":"2025-04-04","current":-5.335216,"twenty":-9.686466,"median":-1.234683,"eighty":-0.670336,"marketCap":146824541},{"date":"2025-04-11","current":-5.024558,"twenty":-9.677786,"median":-1.246122,"eighty":-0.671169,"marketCap":138275264},{"date":"2025-04-17","current":-5.348723,"twenty":-9.677786,"median":-1.251318,"eighty":-0.675865,"marketCap":147196249},{"date":"2025-04-25","current":-6.105108,"twenty":-9.655822,"median":-1.261975,"eighty":-0.677237,"marketCap":168011880},{"date":"2025-05-02","current":-6.051081,"twenty":-9.650331,"median":-1.263712,"eighty":-0.677325,"marketCap":166525049},{"date":"2025-05-09","current":-5.672888,"twenty":-9.649997,"median":-1.269047,"eighty":-0.677795,"marketCap":156117234},{"date":"2025-05-16","current":-4.12907,"twenty":-9.649913,"median":-1.275205,"eighty":-0.67791,"marketCap":150913326},{"date":"2025-05-23","current":-3.742605,"twenty":-9.622773,"median":-1.277009,"eighty":-0.67791,"marketCap":136788433},{"date":"2025-05-30","current":-4.230771,"twenty":-9.615988,"median":-1.27716,"eighty":-0.679079,"marketCap":154630403},{"date":"2025-06-06","current":-3.986688,"twenty":-9.615988,"median":-1.281039,"eighty":-0.681344,"marketCap":145709418},{"date":"2025-06-13","current":-3.884987,"twenty":-9.579719,"median":-1.288108,"eighty":-0.683019,"marketCap":141992341},{"date":"2025-06-20","current":-3.457842,"twenty":-9.549426,"median":-1.293612,"eighty":-0.684245,"marketCap":126380618},{"date":"2025-06-27","current":-3.356141,"twenty":-9.5156,"median":-1.29788,"eighty":-0.686761,"marketCap":122663541},{"date":"2025-07-03","current":-3.844307,"twenty":-9.478617,"median":-1.299848,"eighty":-0.688871,"marketCap":140505510},{"date":"2025-07-11","current":-4.068049,"twenty":-9.478617,"median":-1.307438,"eighty":-0.689433,"marketCap":148683080},{"date":"2025-07-18","current":-3.864647,"twenty":-9.46488,"median":-1.318029,"eighty":-0.690751,"marketCap":141248926},{"date":"2025-07-25","current":-3.762946,"twenty":-9.409931,"median":-1.334256,"eighty":-0.691557,"marketCap":137531849},{"date":"2025-08-01","current":-3.213759,"twenty":-9.403062,"median":-1.344924,"eighty":-0.692413,"marketCap":117459633},{"date":"2025-08-08","current":-3.152738,"twenty":-9.375588,"median":-1.355762,"eighty":-0.694003,"marketCap":115229387},{"date":"2025-08-15","current":-3.070082,"twenty":-9.37083,"median":-1.368174,"eighty":-0.694331,"marketCap":127423445},{"date":"2025-08-22","current":-3.016221,"twenty":-9.349687,"median":-1.382337,"eighty":-0.69434,"marketCap":125187946},{"date":"2025-08-29","current":-3.30348,"twenty":-9.316493,"median":-1.389174,"eighty":-0.694483,"marketCap":137110608},{"date":"2025-09-05","current":-3.070082,"twenty":-9.217483,"median":-1.413215,"eighty":-0.695004,"marketCap":127423445},{"date":"2025-09-12","current":-3.016221,"twenty":-9.209178,"median":-1.458577,"eighty":-0.695269,"marketCap":125187946},{"date":"2025-09-19","current":-2.764869,"twenty":-9.135188,"median":-1.510053,"eighty":-0.696637,"marketCap":114755617},{"date":"2025-09-26","current":-2.782823,"twenty":-9.135188,"median":-1.547617,"eighty":-0.698503,"marketCap":115500784},{"date":"2025-10-03","current":-2.944406,"twenty":-8.845753,"median":-1.686517,"eighty":-0.702215,"marketCap":122207281},{"date":"2025-10-10","current":-2.980313,"twenty":-8.79206,"median":-1.842628,"eighty":-0.70301,"marketCap":123697614},{"date":"2025-10-17","current":-2.711008,"twenty":-8.756608,"median":-1.87675,"eighty":-0.70301,"marketCap":112520118},{"date":"2025-10-24","current":-2.746915,"twenty":-8.626437,"median":-1.953527,"eighty":-0.704971,"marketCap":114010451},{"date":"2025-10-31","current":-2.62124,"twenty":-8.525577,"median":-1.962058,"eighty":-0.707658,"marketCap":108794287},{"date":"2025-11-07","current":-2.675101,"twenty":-8.443903,"median":-2.030303,"eighty":-0.710345,"marketCap":111029786},{"date":"2025-11-14","current":-2.872591,"twenty":-8.40209,"median":-2.030303,"eighty":-0.710345,"marketCap":119226616},{"date":"2025-11-21","current":-2.413453,"twenty":-8.32926,"median":-2.030303,"eighty":-0.710345,"marketCap":115018218},{"date":"2025-11-28","current":-2.397679,"twenty":-8.179359,"median":-2.030303,"eighty":-0.710345,"marketCap":114266465},{"date":"2025-12-05","current":-2.381905,"twenty":-8.110112,"median":-2.064426,"eighty":-0.713479,"marketCap":113514712},{"date":"2025-12-12","current":-3.747701,"twenty":-8.084298,"median":-2.149732,"eighty":-0.714672,"marketCap":178604634},{"date":"2025-12-19","current":-4.10404,"twenty":-8.056808,"median":-2.200917,"eighty":-0.714734,"marketCap":195586714},{"date":"2025-12-26","current":-4.05489,"twenty":-8.015613,"median":-2.200917,"eighty":-0.714734,"marketCap":193244358},{"date":"2026-01-02","current":-5.883801,"twenty":-7.916734,"median":-2.200917,"eighty":-0.714734,"marketCap":280404994},{"date":"2026-01-09","current":-4.793145,"twenty":-7.800301,"median":-2.200917,"eighty":-0.714734,"marketCap":228427483},{"date":"2026-01-16","current":-4.735742,"twenty":-7.775213,"median":-2.200917,"eighty":-0.714734,"marketCap":225691824},{"date":"2026-01-23","current":-5.166265,"twenty":-7.638936,"median":-2.200917,"eighty":-0.714734,"marketCap":246209263},{"date":"2026-01-30","current":-4.506131,"twenty":-7.482348,"median":-2.200917,"eighty":-0.714734,"marketCap":214749190},{"date":"2026-02-06","current":-4.534832,"twenty":-7.344788,"median":-2.200917,"eighty":-0.714734,"marketCap":216117019},{"date":"2026-02-13","current":-4.707041,"twenty":-7.183132,"median":-2.200917,"eighty":-0.714734,"marketCap":224323995},{"date":"2026-02-20","current":-4.994056,"twenty":-7.133933,"median":-2.200917,"eighty":-0.714734,"marketCap":238002287},{"date":"2026-02-27","current":-5.998607,"twenty":-7.033214,"median":-2.200917,"eighty":-0.714734,"marketCap":285876311},{"date":"2026-03-06","current":-5.424578,"twenty":-6.933272,"median":-2.200917,"eighty":-0.714734,"marketCap":258519726},{"date":"2026-03-13","current":-5.711592,"twenty":-6.831707,"median":-2.200917,"eighty":-0.714734,"marketCap":272198018},{"date":"2026-03-20","current":-5.252369,"twenty":-6.772324,"median":-2.200917,"eighty":-0.714734,"marketCap":250312750},{"date":"2026-03-27","current":-5.756175,"twenty":-6.67708,"median":-2.200917,"eighty":-0.714734,"marketCap":277788339},{"date":"2026-04-02","current":-6.391826,"twenty":-6.641938,"median":-2.200917,"eighty":-0.714734,"marketCap":308464352},{"date":"2026-04-10","current":-5.968059,"twenty":-6.53651,"median":-2.200917,"eighty":-0.714734,"marketCap":288013676},{"date":"2026-04-16","current":-6.321198,"twenty":-6.373209,"median":-2.200917,"eighty":-0.714734,"marketCap":305055906}],"updateTime":1776480055219},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IKT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626592110","title":"Buy Rating on IKT-001: De-Risked Late-Stage PAH Program with Adaptive Phase 3 Design and Solid Financial Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2626592110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626592110?lang=en_us&edition=fundamental","pubTime":"2026-04-09 02:55","pubTimestamp":1775674523,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy reiterated a Buy rating on Inhibikase Therapeutics yesterday and set a price target of $8.00. Jason McCarthy has...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-ikt-001-de-risked-late-stage-pah-program-with-adaptive-phase-3-design-and-solid-financial-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-ikt-001-de-risked-late-stage-pah-program-with-adaptive-phase-3-design-and-solid-financial-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT","SSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625910686","title":"Inhibikase Therapeutics: Phase 3 IKT-001 PAH Program and De-Risked Imatinib-Based Efficacy Drive Buy Rating and $8 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2625910686","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625910686?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:16","pubTimestamp":1775643382,"startTime":"0","endTime":"0","summary":"Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Inhibikase Therapeutics and keeping the price target at $8.00. Ram Selvaraju ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/inhibikase-therapeutics-phase-3-ikt-001-pah-program-and-de-risked-imatinib-based-efficacy-drive-buy-rating-and-8-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/inhibikase-therapeutics-phase-3-ikt-001-pah-program-and-de-risked-imatinib-based-efficacy-drive-buy-rating-and-8-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625205953","title":"Inhibikase Begins Pivotal Phase 3 Trial in PAH","url":"https://stock-news.laohu8.com/highlight/detail?id=2625205953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625205953?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:54","pubTimestamp":1775566474,"startTime":"0","endTime":"0","summary":"An announcement from Inhibikase Therapeutics ( ($IKT) ) is now available. On April 7, 2026, Inhibikase Therapeutics announced it had enrolled the f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibikase-begins-pivotal-phase-3-trial-in-pah?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibikase-begins-pivotal-phase-3-trial-in-pah?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625893013","title":"Inhibikase enrolls first patient in Phase 3 IMPROVE-PAH trial for IKT-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2625893013","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625893013?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:06","pubTimestamp":1775563569,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics enrolled first patient in IMPROVE-PAH, a global Phase 3 study of oral PAH candidate IKT-001.Results have not been presented; trial is designed to generate pivotal data to support a potential NDA filing.Study will assess whether IKT-001 can improve pulmonary blood flow function, physical capacity, and disease progression measures versus placebo.Program positions IKT-001 as a reformulated approach to imatinib intended to reduce gastrointestinal side effects seen with the older drug.Trial is planned for up to 180 sites worldwide, using an adaptive design with two sequential parts covering about 486 patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibikase Therapeutics Inc. published the original content u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL6JGtws:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625303479","title":"Inhibikase Therapeutics Announces Enrollment of First Patient in Improve-Pah Global Phase 3 Study of Ikt-001 in the Treatment of Pulmonary Arterial Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2625303479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625303479?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:00","pubTimestamp":1775563202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA4QCJHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624669680","title":"Inhibikase grants 685,718 inducement stock options to five new hires at $1.68/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2624669680","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624669680?lang=en_us&edition=fundamental","pubTime":"2026-04-04 02:01","pubTimestamp":1775239277,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics issued non-qualified stock options covering 685,718 common shares to five newly hired non-executive employees under its 2026 Inducement Equity Plan, effective March 31, 2026.Options carry an exercise price of $1.68 per share.Vesting schedule sets 25% on first anniversary of effective date.Remaining 75% vests in 36 equal monthly installments.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDLb7XQ6s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","NDAQ","BK4585","IE00BGHQF748.EUR","IE00BN0W2W23.USD","SG9999014039.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","LU2095319765.USD","LU2210150020.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4139","IE00B64PRP62.GBP","BK4588","IKT","BK4112","IE00BKPKM429.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624691876","title":"Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624691876","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624691876?lang=en_us&edition=fundamental","pubTime":"2026-04-04 02:01","pubTimestamp":1775239260,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., April  03, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to p","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/03/3268113/0/en/Inhibikase-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623319499","title":"Inhibikase Therapeutics (IKT) Receives a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2623319499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623319499?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:37","pubTimestamp":1774867039,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Inhibikase Therapeutics today and set a price target of $8.00. According to TipRan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inhibikase-therapeutics-ikt-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inhibikase-therapeutics-ikt-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622910818","title":"Inhibikase Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2622910818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622910818?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:26","pubTimestamp":1774560404,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryInhibikase Therapeutics Inc IKT.OQ reported a quarterly adjusted loss of 13 cents per share for the quar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nL8N40E2JY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896941","title":"Inhibikase Therapeutics FY2025 net loss widens 75.39% to $48 million; R&D expenses climb 73.13% to $30 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896941","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896941?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555500,"startTime":"0","endTime":"0","summary":"Inhibikase published a press release reporting full-year 2025 financial results and recent business updates.Net loss was USD 48.3 million, compared with a USD 27.5 million net loss a year earlier.Research and development expense rose 73.2% to USD 29.8 million, including a USD 7.4 million non-cash in-process R&D write-off and USD 2.5 million of stock-based compensation tied to the CorHepta acquisition.Selling, general and administrative expense increased 107% to USD 23.6 million, including USD 1.0 million of severance related to senior executive transitions.Cash, cash equivalents and marketable securities were USD 178.8 million at year-end, and Mark Iwicki said the company has initiated its global pivotal Phase 3 IMPROVE-PAH study  for IKT-001 in pulmonary arterial hypertension, with regulatory submissions filed in more than 20 countries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and ti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL9MQ5ht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622969848","title":"Inhibikase Therapeutics Q1 EPS $(0.10) Beats $(0.13) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2622969848","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622969848?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:04","pubTimestamp":1774555488,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 33.33 percent increase over losses of $(0.15) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51494726/inhibikase-therapeutics-q1-eps-0-10-beats-0-13-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inhibikase Therapeutics Q1 EPS $(0.10) Beats $(0.13) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622089655","title":"Press Release: Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2622089655","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622089655?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:01","pubTimestamp":1774555260,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., March 26, 2026  -- Inhibikase Therapeutics, Inc.  , a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension , today reported financial results for the year ended December 31, 2025 and highlighted recent developments.\"The fourth quarter of 2025 was a transformational quarter for the Company as we transitioned to a global pivotal Phase 3 clinical study in Pulmonary Arterial Hypertension following receipt of a Written Response from a Type C interaction from the United States Food and Drug Administration,\" said Mark Iwicki, Chief Executive Officer of Inhibikase. \"With regulatory submissions in over 20 countries already filed and our first sites initiated, we are well-placed to advance enrollment in our global pivotal study, called IMPROVE-PAH, in PAH.\". -- The Company is advancing IKT-001 into a global pivotal Phase 3 study in. -- The Phase 3 study, named IMPROVE-PAH (IKT-001 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622024521","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2622024521","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622024521?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:00","pubTimestamp":1774432800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOVX","BITF","CELC","AGX","EQ","CNTB","AUTL","BHST","BYND","CTAS","DOO","DERM","MKC","NKE","JBS","KALV","CDLR","FDS","BNZI","CGNT","CNTA","AIRO","DEFT","EDAP","IMNN","CNTX","JILL","CMC","CCL","CGTX","AIRJ","HUMA","JEF","BCAX","AURA","IKT","FUL","BTGO","EPAC","RNXT","KOD","HYPD","IMDX","FEMY","DMAC","ABOS","BIRD","BAK","CHWY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621770492","title":"Inhibikase Therapeutics Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770492","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770492?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:29","pubTimestamp":1774265349,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics Inc  expected to post a loss of10cents a share - Earnings Preview Inhibikase Therapeutics Inc IKT.OQ IKT.O is expected to  show no change in quarterly revenue when it reports  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL8N40B0Y4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621583774","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2621583774","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621583774?lang=en_us&edition=fundamental","pubTime":"2026-03-23 18:00","pubTimestamp":1774260000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDAP","BRZE","CNTA","BTGO","CNXC","CMC","CCL","EPAC","AVTX","IKT","ABSI","MXCT","CHWY","BYND","JEF","CTAS","CNTX","AGX","EVTL","IMNN","BCAX","AUTL","FUL","GUTS","DERM","ABVX","CGNT","DEFT","HYPD","ABOS","FBRX","BZAI","CNTB","HSAI","IMDX","FEMY","KBH","ACHV","DPRO","JBS","CNM","AIR","EQ","HUMA","CELC","BAK","DOO","KALV","FENC","GOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620782840","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2620782840","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620782840?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:00","pubTimestamp":1774000800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQ","GUTS","ABVX","BZAI","EVTL","CNTX","HSAI","BAK","CNM","ACHV","DERM","KRMN","CMC","JBS","HUMA","MXCT","IMNN","KALV","JEF","CNTB","CHWY","ALMS","CTAS","KOD","FBRX","HYPD","CNTA","BCAX","BYND","GOVX","BRZE","CELC","AIR","CNXC","FENC","FUL","AVTX","CGNT","KBH","EPAC","ABSI","IKT","FUFU","FEMY","CUK","EDAP","AGX","DOO","BTGO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2616558166","title":"Inhibikase Therapeutics Initiated at Buy by Ladenburg Thalmann","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558166?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:03","pubTimestamp":1772629380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IKT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2026 08:03 ET (13:03 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616532041","title":"Ladenburg Thalmann Initiates Inhibikase Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532041","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616532041?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:06","pubTimestamp":1772626013,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics (IKT) has an average rating of buy and mean price target of $5.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613718942","title":"Buy Rating on Inhibikase Therapeutics Driven by Rival PAH Setback and Pivotal Phase 3 IMPROVE-PAH Trial for IKT-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2613718942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613718942?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:16","pubTimestamp":1771931799,"startTime":"0","endTime":"0","summary":"Inhibikase Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. Wainwright re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-inhibikase-therapeutics-driven-by-rival-pah-setback-and-pivotal-phase-3-improve-pah-trial-for-ikt-001-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-inhibikase-therapeutics-driven-by-rival-pah-setback-and-pivotal-phase-3-improve-pah-trial-for-ikt-001-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613329867","title":"Analysts’ Top Healthcare Picks: Inhibikase Therapeutics (IKT), Tvardi Therapeutics (TVRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613329867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613329867?lang=en_us&edition=fundamental","pubTime":"2026-02-24 04:01","pubTimestamp":1771876883,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inhibikase Therapeutics (IKT – Research Report) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-inhibikase-therapeutics-ikt-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-inhibikase-therapeutics-ikt-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","XLV","LU0128526141.USD","BK4137","HCSG","LU0029874061.USD","BK4007","LABU","BK4139","IKT","TVRD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}